Ontario, Canada is partnering with Baylis Medical Company to build a new facility and expand its product development.
Steven Del Duca, Minister of Economic Development and Growth, made the announcement recently at Canada’s MedTech Conference in Toronto.
Steven Del Duca, Minister of Economic Development and Growth said, “Supporting forward-thinking and innovative companies like Baylis Medical Company is what the Jobs and Prosperity Fund is all about. Our government is thrilled that the company is expanding in Ontario again, following the success of our first partnership. This will help the company make an even greater impact on helping patients, while accelerating the growth of Ontario’s economy and creating high value jobs in the province.”
Baylis Medical develops and manufactures medical devices that are used in cardiology, radiology and spinal procedures. It is one of the few medtech companies with both research and development (R&D) and manufacturing operations in Canada.
Kris Shah, President, Baylis Medical Company said, “We are pleased to partner with the Ontario government on this expansion, which marks a significant next chapter in the development of our company. The Baylis Medical Innovation Centre will sharpen our competitive edge as we continue to expand our international reach and position our company as a global leader in the medtech sector.”
With support from Ontario’s Jobs and Prosperity Fund, the company is expanding its footprint in Mississauga with a new state-of-the-art “Baylis Medical Innovation Centre” that will centralize the company’s R&D activities.
Amrit Mangat, MPP for Mississauga-Brampton South said, “Baylis Medical is a cornerstone of Mississauga’s thriving medtech sector, and we are thrilled that it is expanding here. With this support from Ontario’s Jobs and Prosperity Fund, Baylis Medical will continue to develop innovative health technologies to help people around the world live healthier lives, while creating good jobs for the local community here in Mississauga.”
This expansion will allow Baylis Medical to develop a number of new product lines, including four technologies that will be produced for the first time, anywhere in the world. It will also help the company expand into new international markets in Europe and Asia.
William Charnetski, Chief Health Innovation Strategist for Ontario said, “Ontario is becoming a global magnet for medtech innovation thanks to homegrown companies like Baylis. Together, we are transforming Ontario’s health system by accelerating the development and adoption of new health technologies that can improve the lives of patients and create jobs.”
